Can-Fite BioPharma Financial Overview
Can-Fite BioPharma's market cap is currently $24.49M. The company's EPS TTM is $-0.14; its P/E ratio is ―; Can-Fite BioPharma is scheduled to report earnings on November 21, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
